These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21239720)

  • 1. Cutting Edge: Selective role of ubiquitin in MHC class I antigen presentation.
    Huang L; Marvin JM; Tatsis N; Eisenlohr LC
    J Immunol; 2011 Feb; 186(4):1904-8. PubMed ID: 21239720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: efficient MHC class I cross-presentation during early vaccinia infection requires the transfer of proteasomal intermediates between antigen donor and presenting cells.
    Serna A; Ramirez MC; Soukhanova A; Sigal LJ
    J Immunol; 2003 Dec; 171(11):5668-72. PubMed ID: 14634072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation.
    Michalek MT; Grant EP; Gramm C; Goldberg AL; Rock KL
    Nature; 1993 Jun; 363(6429):552-4. PubMed ID: 8389422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MHC class I-restricted presentation of maleylated protein binding to scavenger receptors.
    Bansal P; Mukherjee P; Basu SK; George A; Bal V; Rath S
    J Immunol; 1999 Apr; 162(8):4430-7. PubMed ID: 10201979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient and qualitatively distinct MHC class I-restricted presentation of antigen targeted to the endoplasmic reticulum.
    Golovina TN; Wherry EJ; Bullock TN; Eisenlohr LC
    J Immunol; 2002 Mar; 168(6):2667-75. PubMed ID: 11884431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ER stress affects processing of MHC class I-associated peptides.
    Granados DP; Tanguay PL; Hardy MP; Caron E; de Verteuil D; Meloche S; Perreault C
    BMC Immunol; 2009 Feb; 10():10. PubMed ID: 19220912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovalbumin-derived precursor peptides are transferred sequentially from gp96 and calreticulin to MHC class I in the endoplasmic reticulum.
    Kropp LE; Garg M; Binder RJ
    J Immunol; 2010 May; 184(10):5619-27. PubMed ID: 20410492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varied Role of Ubiquitylation in Generating MHC Class I Peptide Ligands.
    Wei J; Zanker D; Di Carluccio AR; Smelkinson MG; Takeda K; Seedhom MO; Dersh D; Gibbs JS; Yang N; Jadhav A; Chen W; Yewdell JW
    J Immunol; 2017 May; 198(10):3835-3845. PubMed ID: 28363906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages.
    Tobian AA; Canaday DH; Boom WH; Harding CV
    J Immunol; 2004 May; 172(9):5277-86. PubMed ID: 15100266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical denaturation and modification of ovalbumin alters its dependence on ubiquitin conjugation for class I antigen presentation.
    Michalek MT; Grant EP; Rock KL
    J Immunol; 1996 Jul; 157(2):617-24. PubMed ID: 8752909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing of recombinant Listeria monocytogenes proteins for MHC class I presentation follows a dedicated, high-efficiency pathway.
    Wolf BJ; Princiotta MF
    J Immunol; 2013 Mar; 190(6):2501-9. PubMed ID: 23396941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of MHC class I-restricted antigen processing and cross-presentation.
    Cresswell P; Ackerman AL; Giodini A; Peaper DR; Wearsch PA
    Immunol Rev; 2005 Oct; 207():145-57. PubMed ID: 16181333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules.
    Yan J; Parekh VV; Mendez-Fernandez Y; Olivares-Villagómez D; Dragovic S; Hill T; Roopenian DC; Joyce S; Van Kaer L
    J Exp Med; 2006 Mar; 203(3):647-59. PubMed ID: 16505142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation.
    Grant EP; Michalek MT; Goldberg AL; Rock KL
    J Immunol; 1995 Oct; 155(8):3750-8. PubMed ID: 7561079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
    Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
    J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tapasin-/- and TAP1-/- macrophages are deficient in vacuolar alternate class I MHC (MHC-I) processing due to decreased MHC-I stability at phagolysosomal pH.
    Chefalo PJ; Grandea AG; Van Kaer L; Harding CV
    J Immunol; 2003 Jun; 170(12):5825-33. PubMed ID: 12794107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Furin-processed antigens targeted to the secretory route elicit functional TAP1-/-CD8+ T lymphocytes in vivo.
    Medina F; Ramos M; Iborra S; de León P; Rodríguez-Castro M; Del Val M
    J Immunol; 2009 Oct; 183(7):4639-47. PubMed ID: 19752221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.
    Fu TM; Guan L; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
    Vaccine; 1998 Nov; 16(18):1711-7. PubMed ID: 9778746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of proteasomal degradation of biosynthesized viral proteins from generation of MHC class I-associated antigenic peptides.
    Antón LC; Snyder HL; Bennink JR; Vinitsky A; Orlowski M; Porgador A; Yewdell JW
    J Immunol; 1998 May; 160(10):4859-68. PubMed ID: 9590233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A transporter associated with antigen-processing independent vacuolar pathway for the MHC class I-mediated presentation of endogenous transmembrane proteins.
    Tiwari N; Garbi N; Reinheckel T; Moldenhauer G; Hämmerling GJ; Momburg F
    J Immunol; 2007 Jun; 178(12):7932-42. PubMed ID: 17548631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.